Consistent with the LC‐MS/MS data, ELISA analysis verified the abnormal expression of CRP and IGFBP2 in the first‐trimester maternal plasma in women who subsequently developed GDM (Figure 5). The gene discussed is IGFBP2; the disease is gestational diabetes.